IRCT20210709051824N1招募中3 期
Assessment of utility of Remdesivir in Patients with Acute Kidney Injury or Cronic Kidney Disease in admitted COVID-19 patients
Men's Health and Reproductive Health Research Center(MHRHRC)0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Patients with acute or chronic renal failure, with a definitive diagnosis of Covid 19, over the age of 18 years, and lung involvement above 20% or hypoxia (oxygen saturation less than or equal to 93%)
- •Definitive diagnosis of Covid 19
- •Over the age of 18 years
- •Pulmonary involvement caused by Covid 19
排除标准
- •Previous history of COVID-19 infection and heart disease and receiving Remdesivir
- •History of lung disease
- •History of liver disease (such as hepatitis, cirrhosis)
- •History of underlying diseases other than renal impairment that contribute to poor prognosis and increased mortality following coronary heart disease (eg, heart failure, active cancer, advanced diabetes with severe macrovascular and microvascular complications, previous stroke)
- •Immunosuppressive use except in the field of kidney transplantation
- •Prohibition of Ramdesivir (except low GFR)
研究者
相似试验
招募中
2 期
Evaluating the effects of remdesivir in severe COVID-19 in hospitalized patientsIRCT20151227025726N28Shahid Beheshti University of Medical Sciences120
已完成
2 期
Effect of remdesivir in COVID-19COVID-19.Corona virus infection, unspecifiedU07.1IRCT20200404046937N5Ahvaz University of Medical Sciences50
尚未招募
不适用
safety of remdesivir use in patients with impaired kidney function and covid 19 infectioCTRI/2020/12/030046DrMaulin Shah
招募中
3 期
Efficacy of Remdesivir in Comparison with Interferon Beta-1 a and Remdesivir in the Treatment of Covid 19IRCT20200721048159N4Vice Chancellor for Research and Technology of Lorestan University of Medical Sciences100
进行中（未招募）
Unknown
ensitrelvir in patients with SARS-CoV-2 infection; a randomized, open-label, molnupiravir-controlled studyJPRN-jRCTs071230014Mukae Hiroshi150